Activities of New Antimicrobial Agents (Trovafloxacin, Moxifloxacin, Sanfetrinem, and Quinupristin-Dalfopristin) against Bacteroides fragilis Group: Comparison with the Activities of 14 Other Agents-Reference-Cited by-同舟云学术

Activities of New Antimicrobial Agents (Trovafloxacin, Moxifloxacin, Sanfetrinem, and Quinupristin-Dalfopristin) against Bacteroides fragilis Group: Comparison with the Activities of 14 Other Agents

Published:1999-09 Issue:9 Volume:43 Page:2320-2322
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Betriu Carmen¹,Gómez María¹,Palau M. Luisa¹,Sánchez Ana¹,Picazo Juan J.¹

Affiliation:

1. Servicio de Microbiologı́a Clı́nica, Hospital Clı́nico San Carlos, 28040 Madrid, Spain

Abstract

ABSTRACT The antimicrobial activities of trovafloxacin, moxifloxacin, sanfetrinem, quinupristin-dalfopristin, and 14 other antimicrobial agents against 218 Bacteroides fragilis group strains were determined. A group of 10 imipenem-resistant strains were also tested. Imipenem, meropenem, and sanfetrinem had the lowest MICs of all of the β-lactams. Quinupristin-dalfopristin inhibited all of the strains at 2 μg/ml. Overall, the MICs of trovafloxacin and moxifloxacin for 90% of the strains tested were 1 and 2 μg/ml, respectively.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.43.9.2320

Reference20 articles.

1. A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamycins, penicillins, clindamycin and metronidazole in the United States.;Aldridge K. E.;Diagn. Microbiol. Infect. Dis.,1994

2. Comparison of the in vitro activities of Bay 12-8039, a new quinolone, and other antimicrobials against clinically important anaerobes

3. Susceptibility of 539 Gram-positive and Gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactam.;Appelbaum P. C.;J. Antimicrob. Chemother.,1993

4. Interactions of β-Lactamases with Sanfetrinem (GV 104326) Compared to Those with Imipenem and with Oral β-Lactams

5. Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study.;Bandoh K.;Clin. Infect. Dis.,1993

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomaterial-Mediated Delivery of Antimicrobial Agents: ‘The Nanocarriers’;Nanotechnology in the Life Sciences;2022

2. Heterogeneity in resistant fecal Bacteroides fragilis group collected from healthy people;Microbial Pathogenesis;2016-06

3. Treatment of Skin and Soft Tissue Infections;Quinolone Antimicrobial Agents;2014-04-08

4. Contemporary Concepts in the Treatment of Chronic Osteomyelitis;Oral and Maxillofacial Surgery Clinics of North America;2007-11

5. Moxifloxacin in the treatment of skin and skin structure infections;Therapeutics and Clinical Risk Management;2006-12